Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
Schönhof Quarter in Frankfurt: Nassauische Heimstätte purchases additional turnkey apartments from Instone Real Estate
Schönhof Quarter in Frankfurt: Nassauische Heimstätte purchases additional turnkey apartments from Instone Real Estate
Schönhof Quarter in Frankfurt: Nassauische Heimstätte purchases additional turnkey apartments from Instone Real Estate
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
DGAP-News: flatex AG: flatex AG: flatex and Societe Generale establish exclusive CFD partnership until 2025
DGAP-News: flatex AG: flatex AG: flatex and Societe Generale establish exclusive CFD partnership until 2025
DGAP-News: flatex AG: flatex AG: flatex and Societe Generale establish exclusive CFD partnership until 2025
DGAP-News: INTERSHOP Communications AG publishes figures for the first nine months of 2019
DGAP-News: INTERSHOP Communications AG publishes figures for the first nine months of 2019
DGAP-News: INTERSHOP Communications AG publishes figures for the first nine months of 2019
Tern PLC: Equity Fundraise of c. £1.75m
Tern PLC: Equity Fundraise of c. £1.75m
Tern PLC: Equity Fundraise of c. £1.75m
Tern PLC: FundamentalVR Series A Funding Round
Tern PLC: FundamentalVR Series A Funding Round
Tern PLC: FundamentalVR Series A Funding Round
DGAP-Adhoc: AURELIUS Equity Opportunities AB considers the issue of up to EUR 200 million senior unsecured bonds
DGAP-Adhoc: AURELIUS Equity Opportunities AB considers the issue of up to EUR 200 million senior unsecured bonds
DGAP-Adhoc: AURELIUS Equity Opportunities AB considers the issue of up to EUR 200 million senior unsecured bonds
DGAP-News: GRENKE AG: GRENKE's business continues to perform well in the third quarter of 2019: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
DGAP-News: GRENKE AG: GRENKE's business continues to perform well in the third quarter of 2019
DGAP-News: GRENKE AG: GRENKE's business continues to perform well in the third quarter of 2019
DGAP-Adhoc: MBH Corporation acquires UK Sports Training Ltd expanding its education services portfolio
DGAP-Adhoc: MBH Corporation acquires UK Sports Training Ltd expanding its education services portfolio
DGAP-Adhoc: MBH Corporation acquires UK Sports Training Ltd expanding its education services portfolio
HanseYachts Aktiengesellschaft: Results 2018/2019
HanseYachts Aktiengesellschaft: Results 2018/2019
HanseYachts Aktiengesellschaft: Results 2018/2019
DGAP-News: RIB Software SE with strong revenue and profit development in Q3 2019 - Recurring revenues (ARR) increase by 112.4% to EUR 25.7 million in Q3
DGAP-News: RIB Software SE with strong revenue and profit development in Q3 2019 - Recurring revenues (ARR) increase by 112.4% to EUR 25.7 million in Q3
DGAP-News: RIB Software SE with strong revenue and profit development in Q3 2019 - Recurring revenues (ARR) increase by 112.4% to EUR 25.7 million in Q3
DGAP-News: Krones AG: Revenue growth of 7.3% in first three quarters of 2019 - structural measures to deliver sustained improvements in earnings launched by Krones Executive Board: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
DGAP-News: Krones AG: Revenue growth of 7.3% in first three quarters of 2019 - structural measures to deliver sustained improvements in earnings launched by Krones Executive Board
DGAP-News: Krones AG: Revenue growth of 7.3% in first three quarters of 2019 - structural measures to deliver sustained improvements in earnings launched by Krones Executive Board
DGAP-News: DIC Asset AG: GEG Acquisition Pays off - with FFO Rising by around 40%Thomas Pfaff Kommunikation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/17644/DIC_Asset_Logo_2014_4C.jpg
DGAP-News: DIC Asset AG: GEG Acquisition Pays off - with FFO Rising by around 40%
DGAP-News: DIC Asset AG: GEG Acquisition Pays off - with FFO Rising by around 40%
DGAP-News: DWS Q3: Third Consecutive Quarter of Net New Assets Marks Flow Turnaround - Cost-Income Ratio Well on Track for Full-Year Target
DGAP-News: DWS Q3: Third Consecutive Quarter of Net New Assets Marks Flow Turnaround - Cost-Income Ratio Well on Track for Full-Year Target
DGAP-News: DWS Q3: Third Consecutive Quarter of Net New Assets Marks Flow Turnaround - Cost-Income Ratio Well on Track for Full-Year Target
EQS-Adhoc: AEVIS VICTORIA SA: Acquisition of the building of Clinique Nescens Paris Spontinihttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
EQS-Adhoc: AEVIS VICTORIA SA: Acquisition of the building of Clinique Nescens Paris Spontini
EQS-Adhoc: AEVIS VICTORIA SA: Acquisition of the building of Clinique Nescens Paris Spontini
DGAP-News: TAG Immobilien AG achieves another increase in quarterly earnings and forecasts 9% increase in FFO and dividend for 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23744/TAG_Immobilien_logo.svg.png
DGAP-News: TAG Immobilien AG achieves another increase in quarterly earnings and forecasts 9% increase in FFO and dividend for 2020
DGAP-News: TAG Immobilien AG achieves another increase in quarterly earnings and forecasts 9% increase in FFO and dividend for 2020
DGAP-News: FUCHS generates sales revenues at previous year's level in the first nine months; decline of 17% in earnings is less significant than expected
DGAP-News: FUCHS generates sales revenues at previous year's level in the first nine months; decline of 17% in earnings is less significant than expected
DGAP-News: FUCHS generates sales revenues at previous year's level in the first nine months; decline of 17% in earnings is less significant than expected
DGAP-News: Klöckner & Co with earnings down in third quarter 2019: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24114/300px-Kl%C3%B6ckner_Logo.jpg
DGAP-News: Klöckner & Co with earnings down in third quarter 2019
DGAP-News: Klöckner & Co with earnings down in third quarter 2019
DGAP-Adhoc: Airbus reports Nine-Month (9m) 2019 results; delivery and FCF outlook updated, EBIT Adjusted guidance maintained: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23690/Airbus_Group_Logo_2014.svg.png
DGAP-Adhoc: Airbus reports Nine-Month (9m) 2019 results; delivery and FCF outlook updated, EBIT Adjusted guidance maintained
DGAP-Adhoc: Airbus reports Nine-Month (9m) 2019 results; delivery and FCF outlook updated, EBIT Adjusted guidance maintained
JSC Halyk Bank: Changes to the Management Board of JSC Halyk Bank
JSC Halyk Bank: Changes to the Management Board of JSC Halyk Bank
JSC Halyk Bank: Changes to the Management Board of JSC Halyk Bank
DGAP-News: MorphoSys AG Reports Third Quarter 2019 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys AG Reports Third Quarter 2019 Financial Results
DGAP-News: MorphoSys AG Reports Third Quarter 2019 Financial Results
DGAP-News: MorphoSys AG: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys AG: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone
DGAP-News: MorphoSys AG: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone
DGAP-Adhoc: MorphoSys AG: Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-Adhoc: MorphoSys AG: Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone
DGAP-Adhoc: MorphoSys AG: Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone
Custodian REIT plc : Issue of equity
Custodian REIT plc : Issue of equity
Custodian REIT plc : Issue of equity